MacroGenics, Inc. (MGNX)
3.07
+0.17
(+5.86%)
USD |
NASDAQ |
Apr 02, 16:00
3.10
+0.03
(+0.98%)
After-Hours: 20:00
MacroGenics EPS Diluted (Quarterly) : -0.2236 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Merck & Co., Inc. | 1.191 |
| CorMedix, Inc. | 0.1493 |
| Xencor, Inc. | -0.0892 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.16M |
| Revenue (Quarterly) | 41.23M |
| Total Expenses (Quarterly) | 55.38M |
| Enterprise Value | 111.97M |
| Gross Profit Margin (Quarterly) | 71.33% |
| Profit Margin (Quarterly) | -34.33% |
| Earnings Yield | -38.56% |
| Normalized Earnings Yield | -38.55 |